Default company panoramic image
Logo

Mid-Atlantic BioTherapeutics, Inc. (MABT)

Engineering the next wave in immunotherapy

  • Stage Product In Development
  • Industry Biotechnology
  • Location Doylestown, PA, USA
  • Currency USD
  • Founded July 2011
  • Employees 2
  • Website mid-atlanticbio.com

Company Summary

MABT is a clinical-stage company focused on HIV/AIDS. Our lead compound, IMT504, has shown impressive results in animal safety and efficacy models and in humans, including some exciting new primate data suggesting that IMT504 could help lead to a functional cure for HIV/AIDS. MABT anticipates initiating human testing to show the therapeutic benefit of IMT504 in HIV/AIDS patients.

Team

  • Default avatar
    David Horn, M.D.
    CEO

    Dr. Horn brings over 30 years of research expertise in infectious diseases. He is board-certified in internal medicine and infectious diseases. Dr. Horn has authored or co-authored publications concerning HIV infection and AIDS, fungal diseases, bacterial infections, tuberculosis, medical informatics and sepsis. He is a fellow of the American College of Physicians, and a fellow of the Infectious Disease Society of America. In addition, Dr. Horn h

  • Default avatar
    Dave Jobes, Ph.D.
    President

    Dr. Jobes brings over 15 years of research and business development expertise in virology and HIV, including HIV vaccine development. Dr. Jobes received his Ph.D. in cell and molecular biology from Tulane University. After completing his postdoctoral training at the NIH, Dr. Jobes worked at Applied Biosystems, where he was integrally involved in bringing a novel HIV drug resistance kit to market, ViroSeq®. He then moved to VaxGen where he ran a r

  • Default avatar
    Marcus Conant, M.D.
    Clinical Advisor

    Dr. Marcus A. Conant is an honored and respected pioneer, lecturer, physician and out-spoken advocate for people infected with HIV and AIDS. Among the first physicians to identify AIDS in 1981, he helped create one of the largest private AIDS clinics, was a founder of the San Francisco AIDS Foundation, and his work contributed to development of some of today’s top HIV medications. He continues his strong, passionate and uncompromising demands,

  • Default avatar
    Don Francis, M.D., D.Sc.
    Advisor

    Dr. Donald Francis is a renowned virologist and epidemiologist, with over 30 years experience in epidemic control and vaccines. Dr. Francis’ career has included over 21 years at the CDC, 1971 to 1992, directing eradication programs for Smallpox (WHO) in India, Bangladesh, Sudan and the former Yugoslavia, Cholera in Nigeria, and Ebola in Sudan. Since 1981 he has focused on HIV/AIDS and serves as Coordinator of Laboratory Activities (Atlanta), Cons

Advisors

  • Default avatar
    Michael Shuster, Fenwick & West; Steve Barrett, Wilmer Hale
    Lawyer
    Unconfirmed

Previous Investors

  • Default avatar
    David Horn, M.D.
    Unconfirmed
    Default avatar
    Dave Jobes, Ph.D.
    Unconfirmed